Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Shields

Showing results (1121-1130 of 1,303) with videos related to

Pageof 131
Sort By:
Ocular Oncology and Pathology|April 13, 2019
Primary Intra-Arterial Chemotherapy for Retinoblastoma in the Intravitreal Chemotherapy Era: Five Years of ExperienceLauren A Dalvin, Mamta Kumari, Vera Adobea Essuman, et al.
American Journal of Ophthalmology|December 20, 2024
Favorable Outcomes of Patients With High-Risk Uveal Melanoma Treated With a Novel Linear Accelerator-Based Frameless Fractionated Stereotactic RadiosurgeryLouis Cappelli, Mehak M Khan, Carol L Shields, et al.
Ophthalmology|July 15, 1998
Uveal lymphoid infiltration. Report of four cases and clinicopathologic reviewH E Grossniklaus, D F Martin, R Avery, et al.
Ophthalmic Plastic and Reconstructive Surgery|September 2, 2015
Periocular Melanoma In Situ Treated With ImiquimodMaxwell D Elia, Sara E Lally, Allison M Hanlon, et al.
Orphanet Journal of Rare Diseases|March 25, 2023
Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF<sup>©</sup>) and determination of a threshold score for moderate symptomsAlan L Shields, Fiona Taylor, Roger E Lamoureux, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 15, 2016
Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of RetinoblastomaCarol L Shields, Rodrigo Jorge, Emil Anthony T Say, et al.
Journal of Patient-Reported Outcomes|December 23, 2022
Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial diseaseChad Gwaltney, Jonathan Stokes, Anthony Aiudi, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 15, 2011
Phacomatosis pigmentovascularis of cesioflammea type in 7 patients: combination of ocular pigmentation (melanocytosis or melanosis) and nevus flammeus with risk for melanomaCarol L Shields, Brad E Kligman, Mayerling Suriano, et al.
Orphanet Journal of Rare Diseases|October 10, 2021
Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF<sup>©</sup>Fiona Taylor, Cem Akin, Roger E Lamoureux, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 1, 1996
Familial uveal melanoma, III. Is the occurrence of familial uveal melanoma coincidental?A D Singh, M X Wang, L A Donoso, et al.
Pageof 131

Showing results (1121-1130 of 1,303) with videos related to

Sort By:
Pageof 131
Ocular Oncology and Pathology|April 13, 2019
Primary Intra-Arterial Chemotherapy for Retinoblastoma in the Intravitreal Chemotherapy Era: Five Years of ExperienceLauren A Dalvin, Mamta Kumari, Vera Adobea Essuman, et al.
American Journal of Ophthalmology|December 20, 2024
Favorable Outcomes of Patients With High-Risk Uveal Melanoma Treated With a Novel Linear Accelerator-Based Frameless Fractionated Stereotactic RadiosurgeryLouis Cappelli, Mehak M Khan, Carol L Shields, et al.
Ophthalmology|July 15, 1998
Uveal lymphoid infiltration. Report of four cases and clinicopathologic reviewH E Grossniklaus, D F Martin, R Avery, et al.
Ophthalmic Plastic and Reconstructive Surgery|September 2, 2015
Periocular Melanoma In Situ Treated With ImiquimodMaxwell D Elia, Sara E Lally, Allison M Hanlon, et al.
Orphanet Journal of Rare Diseases|March 25, 2023
Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF<sup>©</sup>) and determination of a threshold score for moderate symptomsAlan L Shields, Fiona Taylor, Roger E Lamoureux, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 15, 2016
Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of RetinoblastomaCarol L Shields, Rodrigo Jorge, Emil Anthony T Say, et al.
Journal of Patient-Reported Outcomes|December 23, 2022
Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial diseaseChad Gwaltney, Jonathan Stokes, Anthony Aiudi, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 15, 2011
Phacomatosis pigmentovascularis of cesioflammea type in 7 patients: combination of ocular pigmentation (melanocytosis or melanosis) and nevus flammeus with risk for melanomaCarol L Shields, Brad E Kligman, Mayerling Suriano, et al.
Orphanet Journal of Rare Diseases|October 10, 2021
Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF<sup>©</sup>Fiona Taylor, Cem Akin, Roger E Lamoureux, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 1, 1996
Familial uveal melanoma, III. Is the occurrence of familial uveal melanoma coincidental?A D Singh, M X Wang, L A Donoso, et al.
Pageof 131